Literature DB >> 19022007

Prophylactic low-energy shock wave therapy improves wound healing after vein harvesting for coronary artery bypass graft surgery: a prospective, randomized trial.

Julia Dumfarth1, Daniel Zimpfer, Margit Vögele-Kadletz, Johannes Holfeld, Florian Sihorsch, Wolfgang Schaden, Martin Czerny, Seyedhossein Aharinejad, Ernst Wolner, Michael Grimm.   

Abstract

BACKGROUND: Wound healing disorders after vein harvesting for coronary artery bypass graft surgery increase morbidity and lower patient satisfaction. Low-energy shock wave therapy (SWT) reportedly improves healing of diabetic and vascular ulcers by overexpression of vascular endothelial growth fractor and downregulation of necrosis factor kappaB. In this study, we investigate whether prophylactic low-energy SWT improves wound healing after vein harvesting for coronary artery bypass graft surgery.
METHODS: One hundred consecutive patients undergoing coronary artery bypass graft surgery were randomly assigned to either prophylactic low-energy SWT (n = 50) or control (n = 50). Low-energy SWT was applied to the site of vein harvesting after wound closure under sterile conditions using a commercially available SWT system (Dermagold; Tissue Regeneration Technologies, Woodstock, GA). A total of 25 impulses (0.1 mJ/mm(2); 5 Hz) were applied per centimeter wound length. Wound healing was evaluated and quantified using the ASEPSIS score. (ASEPSIS stands for Additional treatment, presence of Serous discharge, Erythema, Purulent exudate, Separation of the deep tissue, Isolation of bacteria, and duration of inpatient Stay). Patient demographics, operative data, and postoperative adverse events were monitored.
RESULTS: Patient characteristics and operative data including wound length (SWT 39 +/- 13 cm versus control 37 +/- 11 cm, p = 0.342) were comparable between the two groups. We observed lower ASEPSIS scores indicating improved wound healing in the SWT group (4.4 +/- 5.3) compared with the control group (11.6 +/- 8.3, p = 0.0001). Interestingly, we observed a higher incidence of wound healing disorders necessitating antibiotic treatment in the control group (22%) as compared with the SWT group (4%, p = 0.015). No SWT-associated adverse events were observed in the treatment group.
CONCLUSIONS: As shown in this prospective randomized study, prophylactic application of low-energy SWT improves wound healing after vein harvesting for coronary artery bypass graft surgery.

Entities:  

Mesh:

Year:  2008        PMID: 19022007     DOI: 10.1016/j.athoracsur.2008.07.117

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  Study of vascular injuries using endothelial denudation model and the therapeutic application of shock wave: a review.

Authors:  Cheuk-Kwan Sun; Pei-Lin Shao; Ching-Jen Wang; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2011-04-08       Impact factor: 4.060

2.  Efficacy and safety of extracorporeal shock wave therapy for acute and chronic soft tissue wounds: A systematic review and meta-analysis.

Authors:  Li Zhang; Xiao-Bing Fu; Shuo Chen; Zhan-Bo Zhao; Christoph Schmitz; Chang-Shui Weng
Journal:  Int Wound J       Date:  2018-04-19       Impact factor: 3.315

3.  Shock wave treatment enhances cell proliferation and improves wound healing by ATP release-coupled extracellular signal-regulated kinase (ERK) activation.

Authors:  Anna M Weihs; Christiane Fuchs; Andreas H Teuschl; Joachim Hartinger; Paul Slezak; Rainer Mittermayr; Heinz Redl; Wolfgang G Junger; Harald H Sitte; Dominik Rünzler
Journal:  J Biol Chem       Date:  2014-08-12       Impact factor: 5.157

4.  [Importance of modern treatment procedures for infected and colonized wounds in dermatology].

Authors:  G Daeschlein; S Lutze; A Arnold; S von Podewils; M Jünger
Journal:  Hautarzt       Date:  2014-11       Impact factor: 0.751

5.  Role of extracorporeal shock wave therapy in management of Peyronie's disease: A preliminary report.

Authors:  Rajendra Kashinath Shimpi; Ravi Jineshkumar Jain
Journal:  Urol Ann       Date:  2016 Oct-Dec

6.  Cardiac shockwave therapy in patients with chronic refractory angina pectoris.

Authors:  J Vainer; J H M Habets; S Schalla; A H P Lousberg; C D J M de Pont; S A Vöö; B T Brans; J C A Hoorntje; J Waltenberger
Journal:  Neth Heart J       Date:  2016-05       Impact factor: 2.380

Review 7.  Efficacy and safety of extracorporeal shock wave therapy for orthopedic conditions: a systematic review on studies listed in the PEDro database.

Authors:  Christoph Schmitz; Nikolaus B M Császár; Stefan Milz; Matthias Schieker; Nicola Maffulli; Jan-Dirk Rompe; John P Furia
Journal:  Br Med Bull       Date:  2015-11-18       Impact factor: 4.291

8.  Twelve-Month Efficacy and Safety of Low-Intensity Shockwave Therapy for Erectile Dysfunction in Patients Who Do Not Respond to Phosphodiesterase Type 5 Inhibitors.

Authors:  Amado Bechara; Adolfo Casabé; Walter De Bonis; Pablo Gomez Ciciclia
Journal:  Sex Med       Date:  2016-07-18       Impact factor: 2.491

Review 9.  Extracorporeal shock wave therapy in musculoskeletal disorders: a review.

Authors:  Pietro Romeo; Vito Lavanga; Davide Pagani; Valerio Sansone
Journal:  Med Princ Pract       Date:  2013-11-05       Impact factor: 1.927

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.